1Tan -Chiu E, Wang JP, Costantino JP, et al. Effect of tamoxifen on benign breast disease in women at high risk for breast cancer [ J ]. J Natl Cancer Inst, 2003,95 (4) : 302-307.
2Tan CE, Wang JP, Costantino JP, et al. Effects of tamoxifen on benign breast disease in women at high risk for breast cancer[J] .J Natl Cancer Inst, 2003,95 (4) : 302-307.
3Cuzlck J, Warwick J, Pinney E, et al. Tamoxifen and breast density in women at increased risk of breast cancer[J] .J Natl Cancer Inst,2004,96(8) :621-628.
4Gumm R, Cunnick GH, Mokbel K. Evidence for the management of mastalgia[ J ]. Curr Med Res Opin, 2004,20 ( 5 ) : 681-684.
5Winkler UH, Schindler AE, Brinkmann US, et al. Cyclic progestin therapy for the management of mastopathy and mastodynia[ J]. Gynecol Endocrinol, 2001, [ Suool 6 ] : 37-43.
6Fallois JV, Etterli-Billenkamp U, Schindler EM, et al. Danazol for treatment of fibrocystic mastopathy [ J ]. Zentralbl Gynakol, 1995, 117(9) :457-465.
7Colin C.Treatment of cystic mastopathy with puncture and administration of an LHRH analogue [ J ] . Contracept Fertil Sex, 1994,22 ( 3 ) :183-186.
8Page DL, Dupont W. Anatomic markers of human premalignant and risk of breast cancer[J]. Cancer, 1990,66[6 Suppl] : 1326-1335.
9Jang TJ, Kang MS, Kim H, et al. Increased expression of cyclin D1 ,cyclin E and p21 ( Cipl ) associated with decreased expression of p27( Kipl ) in chemically induced rat mammary carcinogenesis [ J ]. Jpn J Cancer Res,2000,91(12) : 1222-1232.
10Jang TJ, ParK JH, Cho MY, et al. Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1,cyclin E and p21(Cipl) [J] .Cancer Lett,2001,170(2):109-116.
